Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study

MLA

Martin Schönlein, et al. “Risk Factors for Poor Humoral Response to Primary and Booster SARS-CoV-2 Vaccination in Hematologic and Oncological Outpatients-COVIDOUT Study.” Cancer Cell, vol. 40, no. 6, May 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1d8d474443bbfd20a5160e52dd353518&authtype=sso&custid=ns315887.

APA

Martin Schönlein, Victoria Wrage, Susanne Ghandili, Sibylle C. Mellinghoff, Thomas Theo Brehm, Lisa B. Leypoldt, Nils Utz, Roland M. Schrader, Winfried Alsdorf, Niklas Börschel, Lara Bußmann, Martin Schönrock, Dorothea Perlick, Gerhard Schön, Karl Verpoort, Marc Lütgehetmann, Julian Schulze zur Wiesch, Katja C. Weisel, Carsten Bokemeyer, … Marianne Sinn. (2022). Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study. Cancer Cell, 40(6).

Chicago

Martin Schönlein, Victoria Wrage, Susanne Ghandili, Sibylle C. Mellinghoff, Thomas Theo Brehm, Lisa B. Leypoldt, Nils Utz, et al. 2022. “Risk Factors for Poor Humoral Response to Primary and Booster SARS-CoV-2 Vaccination in Hematologic and Oncological Outpatients-COVIDOUT Study.” Cancer Cell 40 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1d8d474443bbfd20a5160e52dd353518&authtype=sso&custid=ns315887.